These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38673014)

  • 1. Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study.
    Venou TM; Vetsiou E; Varelas C; Daniilidis A; Psarras K; Koravou EE; Koutra M; Touloumenidou T; Tsolakidis V; Papalexandri A; Minti F; Mandala E; Dinas K; Vlachaki E; Gavriilaki E
    J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.
    Hulstein JJ; van Runnard Heimel PJ; Franx A; Lenting PJ; Bruinse HW; Silence K; de Groot PG; Fijnheer R
    J Thromb Haemost; 2006 Dec; 4(12):2569-75. PubMed ID: 16968329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Advances in Preeclampsia and HELLP Syndrome.
    Gardikioti A; Venou TM; Gavriilaki E; Vetsiou E; Mavrikou I; Dinas K; Daniilidis A; Vlachaki E
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
    Burwick RM; Feinberg BB
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1059-S1070. PubMed ID: 32986992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
    Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
    BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome.
    van Rijn BB; Franx A; Steegers EA; de Groot CJ; Bertina RM; Pasterkamp G; Voorbij HA; Bruinse HW; Roest M
    PLoS One; 2008 Apr; 3(4):e1865. PubMed ID: 18382655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy.
    Burwick RM; Fichorova RN; Dawood HY; Yamamoto HS; Feinberg BB
    Hypertension; 2013 Dec; 62(6):1040-5. PubMed ID: 24060886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Activation and Thrombotic Microangiopathies.
    Palomo M; Blasco M; Molina P; Lozano M; Praga M; Torramade-Moix S; Martinez-Sanchez J; Cid J; Escolar G; Carreras E; Paules C; Crispi F; Quintana LF; Poch E; Rodas L; Goma E; Morelle J; Espinosa M; Morales E; Avila A; Cabello V; Ariceta G; Chocron S; Manrique J; Barros X; Martin N; Huerta A; Fraga-Rodriguez GM; Cao M; Martin M; Romera AM; Moreso F; Manonelles A; Gratacos E; Pereira A; Campistol JM; Diaz-Ricart M
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1719-1732. PubMed ID: 31694864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor antigen and ADAMTS13 activity assay in pregnant women and severe preeclamptic patients.
    Zhang D; Xiao J; Huang H; Chen J; Liu T; Yin Z; Gao D; Liu Q; Ai J; Chen S
    J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):777-80. PubMed ID: 21181371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.
    Miodownik S; Pikovsky O; Erez O; Kezerle Y; Lavon O; Rabinovich A
    Am J Obstet Gynecol; 2021 Aug; 225(2):177.e1-177.e15. PubMed ID: 33621545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review.
    Abildgaard U; Heimdal K
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):117-23. PubMed ID: 23107053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low whole blood glutathione levels in pregnancies complicated by preeclampsia or the hemolysis, elevated liver enzymes, low platelets syndrome.
    Knapen MF; Mulder TP; Van Rooij IA; Peters WH; Steegers EA
    Obstet Gynecol; 1998 Dec; 92(6):1012-5. PubMed ID: 9840568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome.
    Bazzan M; Todros T; Tedeschi S; Ardissino G; Cardaropoli S; Stella S; Montaruli B; Marchese C; Roccatello D; Cugno M
    Thromb Res; 2020 Dec; 196():167-174. PubMed ID: 32890900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
    Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia.
    Csuka D; Molvarec A; Derzsy Z; Varga L; Füst G; Rigó J; Prohászka Z
    J Reprod Immunol; 2010 Dec; 87(1-2):90-6. PubMed ID: 20952075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology.
    Stepanian A; Cohen-Moatti M; Sanglier T; Legendre P; Ameziane N; Tsatsaris V; Mandelbrot L; de Prost D; Veyradier A;
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1703-9. PubMed ID: 21512165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS13 gene variants and function in women with preeclampsia: a population- based nested case- control study from the HUNT Study.
    von Krogh AS; Kremer Hovinga JA; Romundstad PR; Roten LT; Lämmle B; Waage A; Quist-Paulsen P
    Thromb Res; 2015 Aug; 136(2):282-8. PubMed ID: 26139087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
    Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.